Skip to main content
. 2010 Aug;177(2):698–712. doi: 10.2353/ajpath.2010.091226

Table 1.

Patients’ Information

No. Age (yr) Sex Histopathological diagnosis Operative procedure MPD (mm)* Passage
1 78 F Cholangiocarcinoma Pylorus preserving PD 1.1 P4
2 67 F IPMN Spleen preserving DP 2.5 P3
3 79 F Cholangiocarcinoma Pylorus preserving PD 1.5 P3
4 84 F Pancreatic adenocarcinoma DP 1.9 P2
5 72 M IPMN Duodenum preserving subTP 2.2 P3
6 53 M Well differentiated endocrine tumor Central pancreatectomy 1.1 P3
7 79 M Pancreatic adenocarcinoma DP 1.5 P2
8 80 M Pancreatic adenocarcinoma DP 1.5 P3
9 74 F Cholangiocarcinoma Pylorus preserving PD 3.6 P2
10 64 F Adenocarcinoma of duodenum Subtotal stomach preserving PD 3.4 P2
11 73 M Cholangiocarcinoma rHPD 2.3 P2
12 77 M Cholangiocarcinoma Pylorus preserving PD 1.2 P2

F, female; M, male; IPMN, intraductal papillary mucinous neoplasm; PD, pancreaticoduodenectomy; DP, distal pancreatectomy; subTP, subtotal pancreatectomy; rHPD, right hepatic lobectomy and pylorus preserving pancreaticoduodenectomy. 

*

Diameters of the main pancreatic ducts (MPD) near sample tissues determined by preoperative multidetector computed tomography.